PROGRESS IN PHARMACEUTICAL SCIENCES 2014,38 8 :621-628 621 IMPORTANT AFFAIRS IN PHARMACEUTICAL WORLD Disease Briefing: Ebola Hemorrhagic Fever Thomson Reuters Ebola hemorrhagic fever is a severe hemorrhagic illness caused by infection with one of several Ebola viruses. Ebola viruses have represented a major public health threat in equatorial Africa. The intelligence of Ebola viruses, including classification, transmission, pathogenic mechanisms, risk factors, epidemiology, diagnosis, treatment, current new drugs pipeline and targets for therapeutic intervention, has been reviewed in this paper. Ebola virus; hemorrhagic fever; vaccine; monoclonal antibody; sirna Prog Pharm Sci Aug. 2014 Vol. 38 No. 8
622 Prog Pharm Sci Aug. 2014 Vol. 38 No. 8
623 Prog Pharm Sci Aug. 2014 Vol. 38 No. 8
624 vs Prog Pharm Sci Aug. 2014 Vol. 38 No. 8
625 Prog Pharm Sci Aug. 2014 Vol. 38 No. 8
626 Prog Pharm Sci Aug. 2014 Vol. 38 No. 8
627 O SSRR H d Nicotiana benthamiana Prog Pharm Sci Aug. 2014 Vol. 38 No. 8
628 Prog Pharm Sci Aug. 2014 Vol. 38 No. 8